Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (181-190 of 393) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|March 3, 2020
Effect of Statins on the Risk of Extrahepatic CholangiocarcinomaSravanthi Lavu, Terry M Therneau, William S Harmsen, et al.
Frontiers in Nuclear Medicine|December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypesLaura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
Epigenetics|November 19, 2016
High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liverDan Zhou, Ryan A Hlady, Marissa J Schafer, et al.
Hepatology (Baltimore, Md.)|June 12, 2014
Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptorsKangsheng Tu, Jiachu Li, Vikas K Verma, et al.
Mechanisms of Ageing and Development|December 3, 2014
Short and long telomeres increase risk of amnestic mild cognitive impairmentRosebud O Roberts, Lisa A Boardman, Ruth H Cha, et al.
Theranostics|November 8, 2019
Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNARyan A Hlady, Xia Zhao, Xiaoyu Pan, et al.
Genes, Chromosomes & Cancer|November 25, 2010
Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survivalJu Dong Yang, Zhifu Sun, Chunling Hu, et al.
Hepatology (Baltimore, Md.)|June 11, 2021
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United StatesYi-Te Lee, Jasmine J Wang, Michael Luu, et al.
Cancer Cell|October 12, 2016
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver CancerAngeles Duran, Eloy D Hernandez, Miguel Reina-Campos, et al.
Gastroenterology|October 13, 2006
Advanced cytologic techniques for the detection of malignant pancreatobiliary stricturesLaura E Moreno Luna, Benjamin Kipp, Kevin C Halling, et al.
Pageof 40

Showing results (181-190 of 393) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|March 3, 2020
Effect of Statins on the Risk of Extrahepatic CholangiocarcinomaSravanthi Lavu, Terry M Therneau, William S Harmsen, et al.
Frontiers in Nuclear Medicine|December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypesLaura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
Epigenetics|November 19, 2016
High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liverDan Zhou, Ryan A Hlady, Marissa J Schafer, et al.
Hepatology (Baltimore, Md.)|June 12, 2014
Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptorsKangsheng Tu, Jiachu Li, Vikas K Verma, et al.
Mechanisms of Ageing and Development|December 3, 2014
Short and long telomeres increase risk of amnestic mild cognitive impairmentRosebud O Roberts, Lisa A Boardman, Ruth H Cha, et al.
Theranostics|November 8, 2019
Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNARyan A Hlady, Xia Zhao, Xiaoyu Pan, et al.
Genes, Chromosomes & Cancer|November 25, 2010
Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survivalJu Dong Yang, Zhifu Sun, Chunling Hu, et al.
Hepatology (Baltimore, Md.)|June 11, 2021
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United StatesYi-Te Lee, Jasmine J Wang, Michael Luu, et al.
Cancer Cell|October 12, 2016
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver CancerAngeles Duran, Eloy D Hernandez, Miguel Reina-Campos, et al.
Gastroenterology|October 13, 2006
Advanced cytologic techniques for the detection of malignant pancreatobiliary stricturesLaura E Moreno Luna, Benjamin Kipp, Kevin C Halling, et al.
Pageof 40